Cancer Gene Ther 2009, 16:351–361 PubMedCrossRef 3 Yu JM, Jun ES

Cancer Gene Ther 2009, 16:351–361.BIRB 796 manufacturer PubMedCrossRef 3. Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY, Kim KW, Jung JS: Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett 2007, 257:172–181.PubMedCrossRef 4. Sareddy GR, Challa S, Panigrahi M, Babu PP: Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat astrocytomas induced by transplacental N-ethyl-N-nitrosourea Selleckchem CUDC-907 exposure.

Neurochem Res 2009, 34:1278–188.PubMedCrossRef 5. Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP: Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 2009, 55:307–317.PubMedCrossRef 6. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner SGC-CBP30 solubility dmso A, Smallwood PM, Samos CH, Nusse R, Dawid IB, Nathans J: A new secreted protein that binds to Wnt proteins and inhibits their activities.

Nature 1999, 398:431–436.PubMedCrossRef 7. Ding Z, Qian YB, Zhu LX, Xiong QR: Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma. World J Gastroenterol 2009, 15:2595–2601.PubMedCrossRef 8. Lin YC, You L, Xu Z, He B, Mikami I, Thung E, Chou J, Kuchenbecker K, Kim J, Raz D, Yang CT, Chen JK, Jablons DM: Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. Biochem Biophys Res Commun 2006, 341:635–640.PubMedCrossRef 9. Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM: Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 2004, 64:4717–4720.PubMedCrossRef 10. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R: Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant

canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res 2006, 12:383–391.PubMedCrossRef 11. Taniguchi H, Yamamoto H, Hirata T, Miyamoto Pregnenolone N, Oki M, Nosho K, Adachi Y, Endo T, mai K, Shinomura Y: Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005, 24:7946–7952.PubMedCrossRef 12. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114:97–109.PubMedCrossRef 13. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM: Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 2000, 60:4926–4931.PubMed 14. Reguart N, He B, Xu Z, You L, Lee AY, Mazieres J, Mikami I, Batra S, Rosell R, McCormick F, Jablons DM: Cloning and characterization of the promoter of human Wnt inhibitory factor-1.

Comments are closed.